(Q33332841)

25 July 2017

title

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris (English)

1 reference

25 July 2017

1 reference

Goncalves L

2

0 references

Arshed A Quyyumi

7

object named as

Quyyumi AA

1 reference

25 July 2017

6

Cannon RO 3rd

1 reference

25 July 2017

Unger EF

1

1 reference

25 July 2017

Epstein SE

3

1 reference

25 July 2017

Chew EY

4

1 reference

25 July 2017

Trapnell CB

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Cardiology

25 July 2017

published in

1 reference

25 July 2017

volume

85

1 reference

25 July 2017

issue

12

1 reference

25 July 2017

page(s)

1414-1419

1 reference

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Hypotensive activity of fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

The fate of intravenously administered bFGF and the effect of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

Sustained calcium influx activated by basic fibroblast growth factor in Balb-c 3T3 fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900787-6

10.1016/S0002-9149(00)00787-6

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference